Can We Omit Prophylactic Central Lymph Node Dissection in Patients with Clinically LN Negative Papillary Thyroid Microcarcinoma?.
10.16956/kjes.2016.16.3.79
- Author:
Byeong Ho GHONG
1
;
Jin Woo PARK
;
Seunguk BANG
;
Dongju KIM
Author Information
1. Department of Surgery, Chungbuk National University, College of Medicine, Cheongju, Korea. reallydong@hanmail.net
- Publication Type:Original Article
- Keywords:
Lymph node metastasis;
Papillary thyroid microcarcinoma;
Recurrence
- MeSH:
Disease-Free Survival;
Female;
Humans;
Lymph Node Excision*;
Lymph Nodes*;
Male;
Medical Records;
Neck Dissection;
Neoplasm Metastasis;
Prognosis;
Recurrence;
Risk Factors;
Thyroid Gland*;
Thyroid Neoplasms;
Thyroidectomy
- From:Korean Journal of Endocrine Surgery
2016;16(3):79-84
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Although papillary thyroid microcarcinoma (PTMC) has very excellent prognosis, lymph node metastases are found frequently. This study identifies the risk factors of clinically negative cervical lymph node metastasis (cN0) and investigates the need for central lymph node dissection in cN0 PTMC. METHODS: From Jan. 1(st) 2007 to Dec. 30(th) 2013, 1593 patients received surgery for papillary thyroid carcinoma. Seven hundred and eleven patients were diagnosed with cN0 PTMCs. They all received thyroidectomy (total thyroidectomy or lobectomy) with prophylactic central neck dissection. We reviewed the medical records and analyzed the risk factors affecting central lymph node metastasis (CLNM). RESULTS: Of 711 PTMCs patients without clinical lymph node metastasis, 170 (23.9%) patients had CLNM. CLNM was frequent in males than females (P<0.001). The larger the primary tumor, the higher the risk of CLNM (P<0.001). Extra-thyroidal extension was an independent risk factor of CLNM (P<0.001). Recurrence rates in the CLNM negative group was 1.3%, and in the CLNM positive group 2.4%. The CLNM positive group recurred at a slightly higher rate, but not statistically significantly (P=0.329). Five year disease free survival in the CLNM negative was 96.8%, and in the positive group 94.1%, not a statistically significant (P=0.630). CONCLUSION: In this study, male gender, the size of primary tumor, and extra-thyroidal extension were the risk factors of occult LNM but occult LNM in PTMC was not associated with recurrence rate or five-year disease free survivals. Therefore, we can omit prophylactic central lymph node dissection in patient with cN0 PTMC.
